FILINGS
| IONS 0000874015 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2026-05-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-05-04 | 144 | View Document | |
| 2026-04-30 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-04-30 | SCHEDULE 13G | View Document | |
| 2026-04-29 | 10-Q | IONIS PHARMACEUTICALS, INC. 10-Q 03-31-2026 | View Document |
| 2026-04-29 | 8-K | 8-K | View Document |
| 2026-04-28 | 144 | View Document | |
| 2026-04-23 | ARS | ARS | View Document |
| 2026-04-23 | DEFA14A | DEFA14A | View Document |
| 2026-04-23 | DEF 14A | DEF 14A | View Document |
| 2026-04-21 | 8-K | 8-K | View Document |
| 2026-04-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-04-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-04-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-04-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-04-16 | 144 | View Document | |
| 2026-04-16 | 144 | View Document | |
| 2026-04-16 | 144 | View Document | |
| 2026-04-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-04-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-31 | 144 | View Document | |
| 2026-03-27 | SCHEDULE 13G/A | View Document | |
| 2026-03-24 | 144/A | View Document | |
| 2026-03-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-19 | 144 | View Document | |
| 2026-03-18 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-16 | 144 | View Document | |
| 2026-03-11 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-11 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-11 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-10 | 144 | View Document | |
| 2026-03-09 | 144 | View Document | |
| 2026-03-09 | 8-K | 8-K | View Document |
| 2026-03-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-03 | 144/A | View Document | |
| 2026-03-03 | 144 | View Document | |
| 2026-03-03 | 144 | View Document | |
| 2026-03-03 | 144 | View Document | |
| 2026-03-03 | 144 | View Document | |
| 2026-03-03 | 144 | View Document | |
| 2026-03-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-03-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-26 | 10-K | IONIS PHARMACEUTICALS, INC. 10-K 12-31-2025 | View Document |
| 2026-02-25 | 8-K | 8-K | View Document |
| 2026-02-17 | SCHEDULE 13G/A | View Document | |
| 2026-02-13 | 4/A | PRIMARY DOCUMENT | View Document |
| 2026-02-13 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-13 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-13 | 144 | View Document | |
| 2026-02-11 | 144 | View Document | |
| 2026-02-10 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-06 | 144 | View Document | |
| 2026-02-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-02-02 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-30 | 144 | View Document | |
| 2026-01-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-23 | 144/A | View Document | |
| 2026-01-22 | 144 | View Document | |
| 2026-01-21 | 144 | View Document | |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4/A | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2026-01-16 | 144 | View Document | |
| 2026-01-16 | 144 | View Document | |
| 2026-01-16 | 144 | View Document | |
| 2026-01-16 | 144 | View Document | |
| 2026-01-16 | 144 | View Document | |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.